RxDoctor Payments Data

Lisa Barker, MD

Family Medicine · Benton, ARNPI 1235209198

Payments from drug & device makers

$2,062in general payments, 2019–2025

Across 140 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$796
  • GSK$201
  • Abbott$199
  • Astellas Pharma US Inc$140
  • Pfizer$110
  • AstraZeneca$102
  • plus $513 from 15 others

What the payments were for

  • Food & beverage$2,062100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,062 in reported general payments places this provider in the 70th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$129,654
Medicare patients
339
Services billed
3,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide137$130,750
EliquisApixaban80$51,330
AustedoDeutetrabenazine11$50,801
JanuviaSitagliptin Phosphate38$38,193
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$36,623
JardianceEmpagliflozin40$31,125
JanumetSitagliptin Phos/Metformin Hcl11$17,881
ElmironPentosan Polysulfate Sodium12$11,835
MyrbetriqMirabegron18$11,381
XareltoRivaroxaban12$10,143
Bydureon BciseExenatide Microspheres13$9,170
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$8,203
Tresiba Flextouch U-200Insulin Degludec12$7,128
Breo ElliptaFluticasone/Vilanterol13$5,191
Pregabalin135$4,869

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$17$130,750137 claims
PfizerEliquis$110$51,33080 claims
Teva Pharmaceuticals USA, Inc.Austedo$14$50,80111 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$201$50,01782 claims
Boehringer IngelheimJardiance$17$31,12540 claims
Astellas Pharma US IncMyrbetriq$140$11,38118 claims
Johnson & JohnsonXarelto$13$10,14312 claims
AbbVieSynthroid$796$1,59338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Benton

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →